Vx-950 and Loraz drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Vx-950 and Loraz. Common interactions include urinary tract infection among females and fatigue among males.
The phase IV clinical study analyzes what interactions people who take Vx-950 and Loraz have. It is created by eHealthMe based on reports of 28 people who take Vx-950 and Loraz from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
28 people who take Vx-950 and Loraz together, and have interactions are studied.
What is Vx-950?
Vx-950 has active ingredients of telaprevir. eHealthMe is studying from 9,465 Vx-950 users for its effectiveness, alternative drugs and more.
What is Loraz?
Loraz has active ingredients of lorazepam. It is often used in stress and anxiety. eHealthMe is studying from 145,138 Loraz users for its effectiveness, alternative drugs and more.
Number of Vx-950 and Loraz reports submitted per year:

Common Vx-950 and Loraz drug interactions by gender *:
female:
- Urinary tract infection
- Nausea
- Fatigue
- Rash
- Pruritus
- Vomiting
- Abdominal pain
- Dysgeusia
- Influenza like illness
- Platelet count decreased
male:
- Fatigue
- Diarrhoea
- Injection site erythema
- Nausea
- Platelet count decreased
- Psychotic disorder
- Stomatitis
- Rash
- Asthenia
- Biliary anastomosis complication
Common Vx-950 and Loraz drug interactions by age *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
- Throat tightness
- Urinary tract infection
- Vomiting
- Fatigue
- Nausea
- Dizziness
- Dysgeusia
- Biliary anastomosis complication
- Blood alkaline phosphatase increased
- Blood creatine phosphokinase increased
50-59:
- Nausea
- Fatigue
- Abdominal pain
- Rash
- Vomiting
- Platelet count decreased
- Constipation
- Diarrhoea
- Injection site erythema
- Liver disorder
60+:
- Rash
- Nausea
- Dry throat
- Dyspnoea
- Eating disorder
- Fatigue
- Headache
- Leukopenia
- Lung infection
- Pancreatitis acute
Common conditions people have *:
- Hepatitis C: 24 people, 85.71%
- Insomnia (sleeplessness): 4 people, 14.29%
- Rashes (redness): 2 people, 7.14%
- Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets): 2 people, 7.14%
- Itching: 2 people, 7.14%
- Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 2 people, 7.14%
- High Blood Pressure: 2 people, 7.14%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 7.14%
- Fever: 2 people, 7.14%
* Approximation only. Some reports may have incomplete information.
Do you take Vx-950 and Loraz?
Personalize this study to your gender and ageHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related studies
Alternative drugs to, pros and cons of the 2 drugs:
Browse all drug interactions of Vx-950 and Loraz:
a b c d e f g h i j k l m n o p q r s t u v w x y zCommon Vx-950 side effects:
- Fatigue (feeling of tiredness): 2,637 reports
- Rashes (redness): 1,841 reports
- Itching: 1,164 reports
- Appetite - decreased (decreased appetite occurs when you have a reduced desire to eat): 855 reports
- Headache (pain in head): 793 reports
- Diarrhea: 711 reports
Browse all side effects of Vx-950:
a b c d e f g h i j k l m n o p q r s t u v w x y zCommon Loraz side effects:
- Fatigue (feeling of tiredness): 10,550 reports
- Drug ineffective: 8,056 reports
- Stress and anxiety: 7,587 reports
- Diarrhea: 7,460 reports
- Breathing difficulty: 6,947 reports
- Pain: 6,807 reports
- Weakness: 6,628 reports
Browse all side effects of Loraz:
a b c d e f g h i j k l m n o p q r s t u v w x y zCommon Vx-950 interactions:
- Vx-950 and Ribavirin: 6,649 reports
- Vx-950 and Pegasys: 5,649 reports
- Vx-950 and Peginterferon: 1,841 reports
- Vx-950 and Pegintron: 1,144 reports
- Vx-950 and Rebetol: 1,032 reports
- Vx-950 and Ribasphere: 660 reports
- Vx-950 and Ribapak: 501 reports
- Vx-950 and Copegus: 430 reports
- Vx-950 and Lisinopril: 148 reports
- Vx-950 and Omeprazole: 146 reports
Browse all interactions between Vx-950 and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zCommon Loraz interactions:
- Loraz and Omeprazole: 13,891 reports
- Loraz and Aspirin: 13,728 reports
- Loraz and Gabapentin: 12,697 reports
- Loraz and Prednisone: 11,464 reports
- Loraz and Furosemide: 11,114 reports
- Loraz and Ondansetron: 10,879 reports
- Loraz and Pantoprazole: 10,751 reports
- Loraz and Lisinopril: 9,193 reports
- Loraz and Morphine: 8,612 reports
- Loraz and Amlodipine: 8,451 reports
Browse all interactions between Loraz and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on telaprevir and lorazepam (the active ingredients of Vx-950 and Loraz, respectively), and Vx-950 and Loraz (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Vx-950 and Loraz.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Xarelto and Regranex drug interaction - 2 seconds ago
- Depakene and Catheter Related Complication - 7 seconds ago
- Pantoprazole and Burning Sensation - 12 seconds ago
- Norepinephrine Bitartrate and Nasal Cavity Mass - 12 seconds ago
- Miralax and Auricular Swelling - 21 seconds ago
- Cortril and Cytomegalovirus Enterocolitis - 22 seconds ago
- Ursodiol and Hypercalcaemia - 27 seconds ago
- Somatuline Depot and Requip drug interaction - 32 seconds ago
- Vitamin D and Cartilage Injury - 51 seconds ago
- Propranolol Hydrochloride and Simvastatin drug interaction - 59 seconds ago